NyseDayTrader
$HYFT WAKE UP. READ WHAT MANAGEMENT ACTUALLY SAID. This isn't “we launched ReefIQ and hope someone buys it.”MULTIPLE LARGE PHARMA companies are already negotiating enterprise deployments. One potential customer has worked with MindWalk FOR YEARS, already has a SaaS subscription, and has been negotiating across MULTIPLE JURISDICTIONS for quite some time. CEO Jennifer Bath:“We have a very good line of sight on where and how this is going and when we anticipate it closing.”And it gets better. ReefIQ opportunities are SUBSTANTIALLY LARGER than historical LensAI agreements.🔥 80% of the pipeline BY VALUE is shifting toward partnership structures. New partnerships can include UPFRONT PAYMENTS + MILESTONES + ROYALTIES. Majority of early ReefIQ interest is coming from LARGE PHARMA. $30M unsecured credit facility. NO equity issuance.🔥 And that DOESN'T replace separate asset-level financing — management says those Cayman structures are already 90–95% through the legal/tax setup, with interested investors. The Street is staring at $3.8M quarterly revenue. I'm staring at WHAT THIS BUSINESS COULD LOOK LIKE AFTER THE FIRST MAJOR REEFIQ DEAL CLOSES. NAME THE PARTNER. SHOW US THE CONTRACT!
13
